Discover
NBY
NovaBay Pharmaceuticals, Inc.
1.47
300 x undefined
200 x undefined
bid
ask
-
0.48
24.62%
12:37 PM
| Ytd | -94.79% | |
| 1y | -47.32% |
1.47
day range
1.47
1.11
52 week range
99.75
| Open | 1.47 | Prev Close | 1.95 | Low | 1.47 | High | 1.47 | Mkt Cap | 39.14M |
| Vol | 86.83K | Avg Vol | 552.07K | EPS | -28.50 | P/E | -0.05 | Forward P/E | -0.63 |
| Beta | 0.26 | Short Ratio | 0.07 | Inst. Own | 2.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 3.53 | 200-d Avg | 9.62 | 1yr Est | 3.73 |
| Income Statement | |||
| Total Revenue | -521.00K | ||
| Revenues (USD) | -521.00K | ||
| Cost of Revenue | -479.00K | ||
| Gross Profit | -42.00K | ||
| Operating Expenses | 1.96M | ||
| Selling, General and Administrative Expense | 1.78M | ||
| Operating Income | -2.00M | ||
| Net Income | -26.60M | ||
| Net Income Common Stock | -26.60M | ||
| Net Income Common Stock (USD) | -26.60M | ||
| Consolidated Income | -26.60M | ||
| Net Income from Discontinued Operations | 1000 | ||
| Earnings per Basic Share | -7.70 | ||
| Earnings per Basic Share (USD) | -7.70 | ||
| Earnings per Diluted Share | -28.88K | ||
| Earning Before Interest & Taxes (EBIT) | -26.60M | ||
| Earning Before Interest & Taxes (USD) | -26.60M | ||
| Weighted Average Shares | 5.82M | ||
| Weighted Average Shares Diluted | 5.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.96M | ||
| Cash and Equivalents (USD) | 7.96M | ||
| Current Assets | 8.68M | ||
| Total Assets | 9.04M | ||
| Debt Current | 489.00K | ||
| Total Debt | 776.00K | ||
| Current Liabilities | 1.14M | ||
| Debt Non-Current | 287.00K | ||
| Total Liabilities | 31.86M | ||
| Accumulated Retained Earnings (Deficit) | -210.41M | ||
| Shareholders Equity | -23.18M | ||
| Shareholders Equity (USD) | -23.18M | ||
| Assets Non-Current | 360.00K | ||
| Total Debt (USD) | 776.00K | ||
| Liabilities Non-Current | 30.72M | ||
| Trade and Non-Trade Payables | 257.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.00K | ||
| Net Cash Flow from Financing | 7.82M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.52M | ||
| Issuance (Purchase) of Equity Shares | -851.00K | ||
| Issuance (Repayment) of Debt Securities | 7.00K | ||
| Payment of Dividends & Other Cash Distributions | -2.00K | ||
| Net Cash Flow from Operations | -2.27M | ||
| Share Based Compensation | 23.00K | ||